FRANKFURT AM MAIN, GERMANY — Vivlion GmbH today announced the execution of a non-exclusive license agreement with the Broad Institute of MIT and Harvard. The agreement provides Vivlion with access to CRISPR/Cas9 intellectual property from the Broad Institute and its partners. Vivlion is a Frankfurt-based startup company providing next generation CRISPR/Cas gRNA libraries and screening services for the […]
The Nomination Committee proposes that Genovis should expand its Board of Directors at the 2021 Annual General Meeting and proposes Steve Jordan to be elected as a new board member. Steve Jordan was born in 1953 and resides in the United Kingdom. He is currently working as a consultant for several companies engaged in development […]
Jon Kratochvil joins as Vice President for Business Development & Licensing for North America DUBLIN, Ireland, 01 March 2021: ERS Genomics Limited (“ERS”), which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, today announced the appointment of Jon Kratochvil as Vice-President for Business Development & Licensing for […]
Data in Twenty-One Poster and Oral Presentations Highlight use of GeoMx Digital Spatial Profiler and the Spatial Molecular Imager Platform for Discovery and Translational Applications SEATTLE — NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the launch of a Technology Access Program (TAP) for […]
Loveland, Colo. – Hach® (www.hach.com), a global leader in water analysis and LuminUltra (luminultra.com), a global leader in biological diagnostic testing, have partnered to offer the world’s first rapid, on-site testing solution for the detection of SARS-CoV-2 in wastewater. SARS-CoV-2 is the virus that causes COVID-19. The partnership is a direct response to consumer and […]
Cota Capital and Section 32 join as investors to support the launch of the Miro Canvas, Miroculus’ first commercial platform. Miroculus, Inc., a developer of revolutionary tools for personal lab automation, today announced the completion of a Series B extension, bringing the total capital raised in the series to $45M. “This round of financing will […]
Nanobody-based chimeric antibodies target fluorescent and structural proteins Munich, Germany and Redcar, UK:. ChromoTek GmbH, part of Proteintech specializing in Nanobody-based reagents, and Absolute Antibody Ltd., a leading provider of recombinant antibody technology, today announced a partnership to offer recombinant engineered antibodies to scientists worldwide. The chimeric antibodies were originally derived from alpaca Nanobodies and engineered onto mouse and […]
BOSTON — Biocytogen, a company dedicated to accelerating therapeutic antibody discovery, has announced the acquisition of a third Beacon Optofluidic system. The new instrument, developed by Berkeley Lights, will support the expansion of Biocytogen’s antibody discovery service platform in the greater Boston area for collaborations across the globe. Founded on its successful gene editing platform, Biocytogen recently developed humanized […]
New kits improve upon well-established ARTIC protocols for SARS-CoV-2 genome sequencing with optimized reagents and improved uniformity of coverage depth for Illumina® and Oxford Nanopore Technologies® next generation sequencing (NGS) platforms IPSWICH, Mass — New England Biolabs (NEB®) today released three kits based on the ARTIC Network protocols for multiplexed amplicon-based sequencing of viral RNA: NEBNext® ARTIC SARS-CoV-2 […]
KANSAS CITY, Mo. and MENLO PARK, Calif. — Pacific Biosciences of California, Inc. (Nasdaq: PACB), a leading provider of high-quality, long-read sequencing platforms, today announced that Children’s Mercy Kansas City, one of the nation’s top pediatric medical centers, has increased its investment in highly accurate HiFi sequencing with four new Sequel IIe Systems to add […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
